UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000016514
Receipt No. R000019178
Scientific Title Evaluation study for clinical utility of multiplex molecular test.in treatment for gastrointestinal infectious disease.
Date of disclosure of the study information 2015/02/16
Last modified on 2019/03/12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Evaluation study for clinical utility of multiplex molecular test.in treatment for gastrointestinal infectious disease.
Acronym GPP Clinical Utility Study
Scientific Title Evaluation study for clinical utility of multiplex molecular test.in treatment for gastrointestinal infectious disease.
Scientific Title:Acronym GPP Clinical Utility Study
Region
Japan

Condition
Condition Patients suspected of community-acquired intestinal tract infection treated at Nagasaki University Hospital
Classification by specialty
Gastroenterology Infectious disease Laboratory medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Evaluate clinical utility and effectiveness of treatment for gastrointestinal infectious disease of xTAG GPP kit by studying a comparison between prospective test and historical control data.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes -Change in the usage of antimicrobial drug
-Period of administration (prescription) of antimicrobial drug
-Clinical impact rate (only in the prospective observation period)
Key secondary outcomes -Total dose of the antimicrobial drugs used (by the type of drug, strain, pathogen)
-Cost analysis (cost of medical resource required for diagnosis, treatment and hospitalization)
-Turn-around-time
-Evaluation of testing performance of Luminex xTAG GPP
-Evaluation of the degree of satisfaction of Luminex xTAG GPP in the aspect of medical care
-Evaluation of the frequency of positive result in the items other than those requested f or usual examination

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Device,equipment Maneuver
Interventions/Control_1 Overview of the prospective observation period (period using the xTAG GPP kit) The xTAG GPP kit test shall be performed in addition to usual care for medical examination.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1.Patients with the symptoms of diarrhea and possible to undergo the test using feces
2.Patients aged 16 years or older
Key exclusion criteria 1.Patients considered inappropriate by the physician in charge

Target sample size 100

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Katsunori Yanagihara
Organization Nagasaki University Hospital
Division name Department of Laboratory Medicine
Zip code
Address 1-7-1 Sakamoto,Nagasaki
TEL 095-819-7574
Email k-yanagi@nagasaki-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Kosuke Kosai
Organization Nagasaki University Hospital
Division name Department of Laboratory Medicine
Zip code
Address 1-7-1 Sakamoto,Nagasaki
TEL 095-819-7574
Homepage URL
Email k-kosai@nagasaki-u.ac.jp

Sponsor
Institute Nagasaki University Hospital
Institute
Department

Funding Source
Organization Luminex Japan Corporation Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 02 Month 16 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 10 Month 17 Day
Date of IRB
2014 Year 10 Month 28 Day
Anticipated trial start date
2015 Year 03 Month 01 Day
Last follow-up date
2016 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 02 Month 12 Day
Last modified on
2019 Year 03 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019178

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.